Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop.
Fahy L, Calvo J, Chabi S, Renou L, Le Maout C, Poglio S, Leblanc T, Petit A, Baruchel A, Ballerini P, Naguibneva I, Haddad R, Arcangeli ML, Mazurier F, Pflumio F, Uzan B.
Fahy L, et al.
Blood Adv. 2021 Jan 26;5(2):513-526. doi: 10.1182/bloodadvances.2020002832.
Blood Adv. 2021.
PMID: 33496749
Free PMC article.